Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site

Journal of Cellular Physiology

Volumn 202, Issue 2, 2005, Pages 391-399

  Varghese, Samuel ^a,b   Rydziel, Sheila ^a   Canalis, Ernesto ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGENASE 3; GROWTH FACTOR; LUCIFERASE; NUCLEOTIDE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CALVARIA; CELL FUNCTION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; FETUS; GEL MOBILITY SHIFT ASSAY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; RAT;

ANIMALS; BINDING SITES; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; COLLAGENASES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; MATRIX METALLOPROTEINASE 13; NEOPLASM PROTEINS; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); RATS; SKULL; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 11144326370     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20130     Document Type: Article

References (66)

1. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. 2001. TGFβ1-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20:2254-2272.
2. Ausubel FM, Brent R, Kingsten RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1992. Current protocols in molecular biology. New York: Greene and Wiley Interscience.
3. Banerjee C, Javed A, Choi J-Y, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2001. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142:4026-4039.
4. Canalis E, Gabbitas B. 1994. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J Bone Miner Res 9:1999-2005.
5. Canalis E, Rydziel S, Delany AM, Varghese S, Jeffrey JJ. 1995. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136:1348-1354.
6. Canalis E, Economides AN, Gazzarro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
7. Centrella M, McCarthy TL, Canalis E. 1987. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874.
8. Centrella M, McCarthy TL, Canalis E. 1991. Transforming growth factor-beta and remodeling of bone. J Bone Joint surg Am 73:1418-1428.
9. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. 1994. Transforming growth factor-beta family members and bone. Endocr Rev 15:27-39.
10. Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshi K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC. 2002. Bone morphogenetic protein 2 induces cyclooxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic 2 in vitro and in vivo. J Bone Miner Res 17:1430-1440.
11. Chiusaroli R, Maier A, Knight MC, Byrne M, Calvi LM, Baron R, Krane SM, Schipani E. 2003. Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments. Endocrinology 144:4106-4116.
12. Delany AM, Jeffrey JJ, Rydziel S, Canalis E. 1995. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. J Biol Chem 270:26607-26612.
13. Ducy P, Karsenty G. 2000. The family of bone morphogenetic proteins. Kidney Int 57:2207-2214.
14. Franceschi RT, Xiao G. 2003. Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
15. Franchimont N, Rydziel S, Delany AM, Canalis E. 1997. Interleukin-6 and its soluble receptor cause a marked induction of collagenase-3 expression in rat osteoblast cultures. J Biol Chem 272:12144-12150.
16. Fry JC. 1993. Biological data analysis: A practical approach. New York: Oxford University Press.
17. Gazzerro E, Gangji V, Canalis E. 1998. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest 102:2106-2114.
18. Gazzerro E, Rydziel S, Canalis E. 1999. Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 in rat osteoblasts. Endocrinology 140:562-567.
19. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo J, Kawabata M, Miyazono K, Ito Y. 1999. Interation and functional cooperation of PEBP2/CBF with Smads. J Biol Chem 274:31577-31582.
20. Harwood AJ. 1994. Protocols for gene analysis. New York: Humana Press.
21. Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F. 1991. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 6:1373-1385.
22. Ho SN, Hunt SD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
23. Hock JM, Canalis E, Centrella M. 1990. Transforming growth factor beta (TGF-beta-1) stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126:421-426.
24. Holliday LS, Welgus HG, Fliszart CJ, Veith GM, Jeffrey JJ, Gluck SL. 1997. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22058.
25. Ito Y, Miyazono K. 2003. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13:43-47.
26. Karsenty G. 2001. Minireview: Transcriptional control of osteoblast development. Endocrinology 142:2731-2733.
27. Kern B, Shen J, Starbuck M, Karsenty G. 2001. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276:7101-7107.
28. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. 1996. Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550.
29. Komori T. 2002. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 87:1-8.
30. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
31. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T. 1998. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption. Endocrinology 139:1338-1345.
32. Lai C-F, Cheng S-L. 2002. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J Biol Chem 277:15514-15522.
33. Lee K-S, Kim H-J, Li Q-L, Chi X-Z, Ueta C, Komori T, Wozney JM, Kim E-G, Choi J-Y, Ryoo H-M, Bae S-C. 2000. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and smad5 induces osteoblast-specific gene expression in the pluripotent mesemchymal precursor cell line C2C12. Mol Cell Biol 20:8783-8792.
34. McCarthy TL, Centrella M, Canalis E. 1988. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 3:401-408.
35. Murphy G. 1995. Matrix metalloproteinase and their inhibitors. Acta Orthop Scand 66(suppl):55-60.
36. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
37. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olson BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
38. Pereira RC, Jorgetti V, Canalis E. 1999. Triidothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol 277:E496-E504.
39. Pereira RC, Economides AN, Canalis E. 2000. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 141:4558-4563.
40. Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P. 1999. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18:667-678.
41. Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. 1990. Rat collagenase: Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 265:22342-22347.
42. Rajkumar RA, Quinn CO. 1996. Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1 binding site. Mol Endocrinol 10:867-878.
43. Rudziel S, Varghese S, Canalis E. 1997. Transforming growth factor B, Mechanisms in osteoblast cultures. J Cell Physiol 170:145-152.
44. Rydziel S, Durant D, Canalis E. 2000. Platelet-derived growth factor induces collagenase-3 transcription in osteoblasts through the activator protein 1 complex. J Cell Physiol 184:326-333.
45. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning-A laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press.
46. Schinke T, Karsenty G. 1999. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters. J Biol Chem 274:30182-30189.
47. Selvamurgan N, Pulumati MR, Tyson DR, Partridge NC. 2000. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor α1. J Biol Chem 275:5037-5042.
48. Selvamurugan N, Chou W, Pearman AT, Pulumati MR, Partridge NC. 1998. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the co-operative interaction of the activator protein-1 site and runt domain binding sequence. J Biol Chem 273:10647-10657.
49. Shui C, Spelsberg TC, Riggs BL, Khosla S. 2003. Changes in Runx2/cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 18:21-221.
50. Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega JA, Lopex-Otin C. 1997. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 76:717-728.
51. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. 1991. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity, and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174:96-101.
52. Tardif G, Pelletier JP, Dupuis M, Geng C, Cloutier JM, Martel-Pelletier J. 1999. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. Arthritis Rheum 42:1147-1158.
53. 3 in mouse osteoblastic MC 3T3-E1 cells. J Bone Miner Res 16:221-230.
54. Varghese S, Canalis E. 1997. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology 138:1035-1040.
55. Varghese S, Canalis E. 2003. Transcriptional regulation of collagenase-3 by interleukin-1 alpha in osteoblasts. J Cell Biochem 90:1007-1014.
56. Varghese S, Rydziel S, Jeffrey JJ, Canalis E. 1994. Regulation of interstitial collagenase expression and collagen degradation by retinoic acid in bone cells. Endocrinology 134:2438-2444.
57. Varghese S, Ramsby ML, Jeffrey JJ, Canalis E. 1995. Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136:2156-2162.
58. Varghese S, Delany AM, Liang L, Gabbitas B, Jeffrey JJ, Canalis E. 1996. Transcriptional and posttranscriptional regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures. Endocrinology 137:431-437.
59. Varghese S, Yu K, Canalis E. 1999. Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts. Am J Physiol 276:E465-E471.
60. Varghese S, Rydziel S, Canalis E. 2000. Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1 binding site. Endocrinology 141:2185-2191.
61. Wee HJ, Huang G, Shigesada K, Ito Y. 2002. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep 3:967-974.
62. Wozney JM. 1992. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167.
63. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. 2000. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
64. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. 2002. Bone morphogenetic proteins, extracellular matrix, and mitogen activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
65. Zhang Y-W, Yasui N, Ito K, Huang G, Fujii M, Hanai J-I, Nogami H, Ochi T, Miyazono K, Ito Y. 2000. A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97:10549-10554.
66. Zhao W, Byrne MH, Boyce BF, Krane SM. 1999. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 103:517-524.